osteoarthritis
Scope
Date
~
-
Bio & PharmaLG Chem launches Synovian in China
South Korea's LG Chem Ltd. announced on Wednesday that it launched its homegrown new drug for osteoarthritis Synovian (marketed in China as Hyruan O...
Jul 03, 2024 (Gmt+09:00)
-
Bio & PharmaCrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn
South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...
Jun 08, 2023 (Gmt+09:00)
-
Bio & PharmaMedipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
Jan 17, 2023 (Gmt+09:00)
-
Bio & PharmaKolon Life inks technology transfer deal with Juniper Biologics
South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...
Apr 13, 2022 (Gmt+09:00)
Latest News
- 1 Micron set to supply SOCAMM chips to Nvidia ahead of Samsung, SK Hynix
- 2 POSCO Future M breaks with China in cathode supply chain
- 3 GIC resumes Seoul Finance Center sale in potential megadeal
- 4 South Korea’s Lee, China’s Xi agree on closer ties, peace on Korean Peninsula
- 5 Invesco, SK D&D likely to buy co-living building in Seoul
